Capstone
$2.99
2
-$0.26-8% Wednesday 17:32
統計
當日最高
3.25
當日最低
3.25
52週最高
7.5
52週最低
3.25
成交量
100
平均成交量
15
市值
709,245
市盈率
-
股息收益率
-
股息
-
收益
7Nov預期
預期每股收益
0
實際每股收益
0
人們還關注
此列表基於在 Stock Events 上關注 CAPS 的人的關注列表。這不是投資建議。
競爭者
這個列表是基於最近市場事件的分析。這不是投資建議。
Cummins
CMI
市值42.88B
Caterpillar
CAT
市值172.67B
Ballard Power Systems
BLDP
市值554.14M
Plug Power
PLUG
市值1.65B
Fuelcell Energy
FCEL
市值201.2M
GE Aerospace
GE
市值189.34B
Honeywell International
HON
市值135.07B
Mastec
MTZ
市值8.96B
Siemens
SIEGY
市值148.79B
關於
Medical Specialties
Health Technology
Manufacturing
Pharmaceutical Preparation Manufacturing
Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.
Show more...
首席執行官
John Holliman
員工
46
國家
US
ISIN
US14068E2081